Search

Your search keyword '"Acinetobacter Infections prevention & control"' showing total 360 results

Search Constraints

Start Over You searched for: Descriptor "Acinetobacter Infections prevention & control" Remove constraint Descriptor: "Acinetobacter Infections prevention & control"
360 results on '"Acinetobacter Infections prevention & control"'

Search Results

151. [Prompt control of an imported carbapenem-resistant Acinetobacter baumanii outbreak in a French intensive care unit].

152. Immunoprotective potential of in silico predicted Acinetobacter baumannii outer membrane nuclease, NucAb.

154. Task force on management and prevention of Acinetobacter baumannii infections in the ICU.

155. Antimicrobial dressings: Comparison of the ability of a panel of dressings to prevent biofilm formation by key burn wound pathogens.

156. Risk factors for central line-associated bloodstream infection in patients with major burns and the efficacy of the topical application of mupirocin at the central venous catheter exit site.

157. Effect of daily chlorhexidine bathing on acquisition of carbapenem-resistant Acinetobacter baumannii (CRAB) in the medical intensive care unit with CRAB endemicity.

158. Fomite-fingerpad transfer efficiency (pick-up and deposit) of Acinetobacter baumannii-with and without a latex glove.

159. Impact of Contact Isolation Precautions on Multi-Drug Resistant Acinetobacter baumannii in the Pediatric Intensive Care Unit.

160. OmpW is a potential target for eliciting protective immunity against Acinetobacter baumannii infections.

161. Infection Control Programs and Antibiotic Control Programs to Limit Transmission of Multi-Drug Resistant Acinetobacter baumannii Infections: Evolution of Old Problems and New Challenges for Institutes.

162. Characterising the Transmission Dynamics of Acinetobacter baumannii in Intensive Care Units Using Hidden Markov Models.

163. Long-term effectiveness of infection and antibiotic control programs on the transmission of carbapenem-resistant Acinetobacter calcoaceticus-Acinetobacter baumannii complex in central Taiwan.

164. Controlling multidrug-resistant Gram-negative bacilli in your hospital: a transformational journey.

165. Control of hospital endemicity of multiple-drug-resistant Acinetobacter baumannii ST457 with directly observed hand hygiene.

166. The activity of silver nanoparticles (Axonnite) on clinical and environmental strains of Acinetobacter spp.

167. Surveillance cultures growing carbapenem-Resistant Acinetobacter baumannii predict the development of clinical infections: a retrospective cohort study.

168. [Prevention of an outbreak of Acinetobacter baumannii in intensive care units: study of the efficacy of different mathematical methods].

169. Identification of novel vaccine candidates against Acinetobacter baumannii using reverse vaccinology.

170. Intranasal immunization protects against Acinetobacter baumannii-associated pneumonia in mice.

171. Current advances and challenges in the development of Acinetobacter vaccines.

172. Immunization with lipopolysaccharide-deficient whole cells provides protective immunity in an experimental mouse model of Acinetobacter baumannii infection.

173. A milk pump as a source for spreading Acinetobacter baumannii in a neonatal intensive care unit.

174. In silico analysis of Acinetobacter baumannii phospholipase D as a subunit vaccine candidate.

175. Risks for multidrug-resistant pathogens in the ICU.

176. Successful control of carbapenem-resistant Acinetobacter baumannii in a Korean university hospital: a 6-year perspective.

177. Effect of a ventilator-focused intervention on the rate of Acinetobacter baumannii infection among ventilated patients.

178. Preventing the transmission of multidrug-resistant organisms: modeling the relative importance of hand hygiene and environmental cleaning interventions.

179. Central line-associated bloodstream infection in a trauma intensive care unit: impact of implementation of Society for Healthcare Epidemiology of America/Infectious Diseases Society of America practice guidelines.

181. Influence of whole-body washing of critically ill patients with chlorhexidine on Acinetobacter baumannii isolates.

182. [Management of a 4MRGN Acinetobacter baumanii outbreak in a burn unit].

183. Molecular characterisation and control of Acinetobacter baumannii isolates resistant to multi-drugs emerging in inter-intensive care units.

184. Impact of daily chlorhexidine baths and hand hygiene compliance on nosocomial infection rates in critically ill patients.

185. Control of simultaneous outbreaks of carbapenemase-producing enterobacteriaceae and extensively drug-resistant Acinetobacter baumannii infection in an intensive care unit using interventions promoted in the Centers for Disease Control and Prevention 2012 carbapenemase-resistant Enterobacteriaceae Toolkit.

186. Next science wound gel technology, a novel agent that inhibits biofilm development by gram-positive and gram-negative wound pathogens.

187. Incidence of bacteremia in cirrhotic patients undergoing upper endoscopic ultrasonography.

188. Tracking bug's spread galvanizes staff.

191. Management and control of a carbapenem-resistant Acinetobacter baumannii outbreak in an intensive care unit.

192. Control of a two-decade endemic situation with carbapenem-resistant Acinetobacter baumannii: electronic dissemination of a bundle of interventions.

193. Effectiveness and cost of implementing an active surveillance screening policy for Acinetobacter baumannii: a Monte Carlo simulation model.

194. Effectiveness of infection prevention measures featuring advanced source control and environmental cleaning to limit transmission of extremely-drug resistant Acinetobacter baumannii in a Thai intensive care unit: An analysis before and after extensive flooding.

195. Infection prevention control bundle of multidrug-resistant Acinetobacter baumannii and methicillin-resistant Staphylococcus aureus: which one is more important?

196. [Acinetobacter: microbiological, pathogenetic and resistant properties].

197. [Investigation of the virulence factors of multidrug-resistant Acinetobacter baumannii isolates].

198. [Eradication of a nosocomial outbreak of multidrug-resistant Acinetobacter baumannii infections after adjusting nursing workloads and reinforcing specific precautions].

199. Identification of novel vaccine candidates against multidrug-resistant Acinetobacter baumannii.

200. Protective effect of procysteine on Acinetobacter pneumonia in hyperoxic conditions.

Catalog

Books, media, physical & digital resources